Therefore, the authors suggested that SPARC, DCN, FBN1, WWTR1, TAGLN, DDX28, and CSDC2 may contribute to the development of early-onset CRC and may serve as potential diagnostic biomarkers. This evidence concerns the gene DCN and colorectal carcinoma.